Dr. Joshua Lukenbill
Claim this profileMedical Oncology and Hematology Associates-Des Moines
Expert in Cancer
Expert in Tumors
140 reported clinical trials
215 drugs studied
About Joshua Lukenbill
Education:
- Earned dual BS degrees in biochemistry and psychology from The University of Iowa.
- Attended medical school at A.T. Still University, Kirksville, MO.
- Completed an Internal Medicine residency and Hematology/Oncology fellowship at The Cleveland Clinic.
Experience:
- Board Certified in Oncology, Hematology, and Internal Medicine.
- Joined Mission in 2017 and is currently practicing in Des Moines, IA.
- Holds roles in research and education with affiliations to Iowa Methodist Medical Center, University of Iowa, and Des Moines University.
- Active member of the American Society of Hematology and American Society of Clinical Oncology.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Tumors
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Joshua Lukenbill is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
More about Joshua Lukenbill
Clinical Trial Related4 years of experience running clinical trials · Led 140 trials as a Principal Investigator · 88 Active Clinical TrialsTreatments Joshua Lukenbill has experience with
- Nivolumab
- Cisplatin
- Radiation Therapy
- Fluorouracil
- Atezolizumab
- Paclitaxel
Breakdown of trials Joshua Lukenbill has run
Cancer
Tumors
Breast Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joshua Lukenbill specialize in?
Joshua Lukenbill focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Joshua Lukenbill currently recruiting for clinical trials?
Yes, Joshua Lukenbill is currently recruiting for 82 clinical trials in Des Moines Iowa. If you're interested in participating, you should apply.
Are there any treatments that Joshua Lukenbill has studied deeply?
Yes, Joshua Lukenbill has studied treatments such as Nivolumab, Cisplatin, Radiation Therapy.
What is the best way to schedule an appointment with Joshua Lukenbill?
Apply for one of the trials that Joshua Lukenbill is conducting.
What is the office address of Joshua Lukenbill?
The office of Joshua Lukenbill is located at: Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa 50309 United States. This is the address for their practice at the Medical Oncology and Hematology Associates-Des Moines.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.